National Vision Holdings, Inc. income statement EYE

In fiscal 2025, which ended Jan 3, 2026, National Vision Holdings, Inc. reported revenue of $2.0 billion, up 9.0% from the year before. Net income was $29.6 million, a profit margin of 1.5%. Operating income came to $58.8 million, an operating margin of 3.0%. Diluted earnings per share were $0.37. Over the twelve months ended Jul 4, 2026, revenue was $2.0 billion and net income was $50.3 million. Across the 9 fiscal years shown, revenue grew from $1.4 billion in fiscal 2017 to $2.0 billion in fiscal 2025, about 4.7% a year.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line
FY 2026
Jul 4, 2026
FY 2025
Jan 3, 2026
FY 2024
Dec 28, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 31, 2022
FY 2021
Jan 1, 2022
FY 2020
Jan 2, 2021
FY 2019
Dec 28, 2019
FY 2018
Dec 29, 2018
FY 2017
Dec 30, 2017
Revenue
2,033
+7.8%
1,987
+9.0%
1,823
+3.8%
1,756
+6.8%
1,645
-20.9%
2,080
+21.5%
1,712
-0.7%
1,724
+12.2%
1,537
+11.7%
1,375
Cost of revenue
—
—
—
—
—
—
—
—
714
+12.0%
637
Gross profit
—
—
—
—
—
—
—
—
823
+11.5%
738
Selling, general and administrative
1,013
+4.5%
1,016
+8.3%
939
+3.7%
905
+8.7%
833
-7.6%
901
+24.3%
725
-2.6%
744
+8.3%
687
+14.6%
600
Other operating income (expense)
0
-19.5%
0
+102.0%
0
-2.9%
0
-95.9%
3
+2.0%
3
+462.9%
0
—
—
—
Operating income
83
+910.3%
59
+667.9%
-10
-142.3%
24
-53.6%
53
-69.8%
175
+101.1%
87
+18.3%
74
+73.7%
42
-34.1%
64
Pretax income
68
+906.4%
42
+262.3%
-26
-368.9%
10
-81.7%
52
-65.0%
149
+286.1%
39
+26.9%
30
+526.3%
5
+15.1%
4
Income tax
18
+175.9%
12
+715.7%
1
-75.3%
6
-61.4%
16
-26.3%
21
+777.3%
2
+204.1%
-2
+87.7%
-19
+51.7%
-39
Net income
50
+455.4%
30
+203.9%
-28
+56.8%
-66
-256.5%
42
-67.2%
128
+253.5%
36
+10.6%
33
+38.7%
24
-45.2%
43
Basic EPS
0.63
+452.7%
0.37
+202.8%
-0.36
+57.1%
-0.84
-258.5%
0.53
-66.2%
1.57
+248.9%
0.45
+7.1%
0.42
+35.5%
0.31
-56.9%
0.72
Diluted EPS
0.62
+445.7%
0.37
+202.8%
-0.36
+57.1%
-0.84
-261.5%
0.52
-63.6%
1.43
+225.0%
0.44
+10.0%
0.40
+33.3%
0.30
-57.1%
0.70
Weighted average shares, basic
79
+0.8%
79
+0.7%
79
+0.4%
78
-1.9%
80
-2.4%
82
+1.6%
81
+2.5%
79
+3.6%
76
+26.7%
60
Weighted average shares, diluted
81
+2.8%
81
+2.5%
79
-0.0%
79
-2.1%
80
-16.5%
96
+16.1%
83
+1.4%
82
+3.3%
79
+27.4%
62
Other measures
Depreciation and amortization
92
+1.5%
91
-0.2%
91
+1.6%
90
+1.3%
89
-8.7%
97
+6.0%
92
+5.0%
87
+17.4%
74
+20.0%
62
EBITDA
175
+76.6%
150
+85.2%
81
-29.2%
114
-19.2%
141
-48.0%
272
+52.3%
179
+11.1%
161
+37.8%
117
-7.6%
126
Interest coverage
—
—
—
—
—
—
—
—
—
1.16x
Margins
Gross margin
—
—
—
—
—
—
—
—
53.57%
53.69%
Operating margin
4.07%
2.96%
-0.57%
1.39%
3.21%
8.41%
5.08%
4.27%
2.76%
4.67%
Pretax margin
3.36%
2.10%
-1.41%
0.54%
3.18%
7.18%
2.26%
1.77%
0.32%
0.31%
Profit margin
2.47%
1.49%
-1.56%
-3.75%
2.56%
6.17%
2.12%
1.90%
1.54%
3.14%
EBITDA margin
8.61%
7.55%
4.44%
6.51%
8.60%
13.08%
10.43%
9.33%
7.59%
9.18%
Effective tax rate
26.30%
28.98%
—
62.88%
29.72%
14.12%
6.21%
-7.57%
-385.89%
-920.29%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

Company profile

Industry
Ophthalmic Goods (SIC 3851)
Listed as
EYE (Nasdaq)
Fiscal year ends
January 2
Incorporated in
DE
Headquarters
Alpharetta, GA
SEC filer status
Large accelerated filer
SEC CIK
1710155

Other Ophthalmic Goods companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.